Effect of milrinone injection for hypertensive heart disease patients with heart failure and its influence on exercise tolerance

ZHANG Jianxia; LI Junnong; HAN Hongmei; GU Jianli

doi:10.7619/jcmp.201915022

Journal of Clinical Medicine in Practice > 2019 > 23(15): 83-85,89. > DOI: 10.7619/jcmp.201915022

ZHANG Jianxia, LI Junnong, HAN Hongmei, GU Jianli. Effect of milrinone injection for hypertensive heart disease patients with heart failure and its influence on exercise tolerance[J]. Journal of Clinical Medicine in Practice, 2019, 23(15): 83-85,89. DOI: 10.7619/jcmp.201915022

Citation:

PDF (656 KB)

Effect of milrinone injection for hypertensive heart disease patients with heart failure and its influence on exercise tolerance

1.
Weinan City Central Hospital, Weinan, Shaanxi, 714000
2.
Pharmaceutical Department, Xi′an Third Hospital, Xi′an, Shaanxi, 710018

More Information

Received Date: May 12, 2019
Revised Date: June 19, 2019
Available Online: February 23, 2021
Published Date: August 14, 2019

Graphical Abstract

Abstract

Abstract

Objective To explore the effect of milrinone injection in the treatment of hypertensive heart disease patients with heart failure and its influence on exercise tolerance.
Methods A total of 94 patients with hypertensive heart disease and heart failure admitted to our hospital were enrolled in the study. According to the random number table Method, they were divided into control group and observation group, with 47 cases in each group. Control group was given conventional treatment such as antihypertensive and anti-heart failure therapies, and observation group was given milrinone injection on the basis of control group. The effects and levels of serum brain natriuretic peptide (BNP) and cardiac troponin I (cTnI) before and after treatment were compared between the two groups. The Yaeger Cardiopulmonary Function Test was used to evaluate the exercise tolerance before and after treatment, and the adverse reactions were recorded.
Results The effective rate in observation group was higher than that in control group (P < 0.05). After treatment, the serum BNP and cTnI levels in observation group were lower than those in the control group (P < 0.05). After treatment, the exercise time, maximum heart rate and maximum oxygen consumption and maximum exercise load in observation group were greater than those in control group (P < 0.05). There was no significant difference in the incidence of total adverse reactions between two groups (P>0.05).
Conclusion Milrinone injection can improve the treatment efficacy of hypertensive heart disease patients with heart failure, reduce myocardial damage and enhance exercise tolerance.
- milrinone injection,
- hypertensive heart disease,
- heart failure,
- exercise tolerance

FullText(HTML)

References (20)

References

[1]	杨婷, 赵茜茜, 崔晓博, 等. 曲美他嗪联合卡维地洛治疗高血压性心脏病心力衰竭的临床效果[J]. 宁夏医科大学学报, 2017, 39(5): 579-582. https://www.cnki.com.cn/Article/CJFDTOTAL-XNXY201705026.htm
[2]	李春雨, 姜婷, 王魏魏, 等. 急诊抢救室心力衰竭患者病因分析及治疗现状[J]. 临床心血管病杂志, 2016, 32(10): 1009-1012. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB201610010.htm
[3]	魏守蓉, 陈敏, 张军辉, 等. 米力农在老年心力衰竭患者辅助治疗中的应用效果[J]. 山东医药, 2015, 55(32): 53-54. doi: 10.3969/j.issn.1002-266X.2015.32.021
[4]	卜庆锋, 刘来勇, 刘杰. 参麦注射液与米力农治疗老年难治性心力衰竭的疗效[J]. 中西医结合心脑血管病杂志, 2016, 14(9): 1045-1046. doi: 10.3969/j.issn.1672-1349.2016.09.042
[5]	Pesinat R M, Yamada A T, Benvenuti L A, et al. Case 01/2015 - 66 Year Old Woman with Hypertensive Cardiopathy and Acute Decompensated Heart Failure[J]. Arquivos Brasileiros De Cardiologia, 2015, 104(5): e39-e48. http://labs.europepmc.org/abstract/MED/26083780/reload=0;jsessionid=uAiRXTOFvcsJsh9zRGYN.42
[6]	夏大胜, 卢成志, 王丽. 经导管去肾交感神经术治疗高血压性心脏病合并心衰患者的效果分析[J]. 天津医药, 2016, 44(2): 234-236. https://www.cnki.com.cn/Article/CJFDTOTAL-TJYZ201602029.htm
[7]	苏衡, 王广艳, 朱君. 米力农注射液治疗高血压性心脏病伴心力衰竭的临床观察[J]. 中国药房, 2017, 28(5): 677-680. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYA201705028.htm
[8]	邹晓光, 朱永艳, 张治成, 等. 米力农对慢性充血性心力衰竭老年患者心功能及血气分析指标的影响[J]. 中华老年医学杂志, 2017, 36(11): 1176-1179. doi: 10.3760/cma.j.issn.0254-9026.2017.11.003
[9]	田福利, 张二箭, 卜雪芹, 等. 慢性心力衰竭应用β受体阻滞剂联合米力农临床疗效观察[J]. 中国循证心血管医学杂志, 2016, 8(10): 1259-1260. doi: 10.3969/j.issn.1674-4055.2016.10.33
[10]	朱磊, 祁伯祥, 胡丹, 等. 米力农联合艾司洛尔对危重型手足口病患儿心功能和心肌酶的影响研究[J]. 中国全科医学, 2015, 18(19): 2306-2309. doi: 10.3969/j.issn.1007-9572.2015.19.015
[11]	苍春阳. 米力农对洋地黄类及利尿剂应用效果不佳的慢性心力衰竭急性发作治疗的临床研究[J]. 陕西医学杂志, 2017, 46(8): 1119-1121. doi: 10.3969/j.issn.1000-7377.2017.08.065
[12]	张胜豪, 刘恒亮, 毛磊, 等. 血清糖类抗原125及脑钠肽水平对心肌梗死后心力衰竭发生及严重程度的预测价值[J]. 中国动脉硬化杂志, 2019, 27(1): 55-60. doi: 10.3969/j.issn.1007-3949.2019.01.011
[13]	马宁, 晁银霞, 杨红, 等. 血浆脑钠肽及血清胱抑素C对ARVC心力衰竭的预测价值研究[J]. 重庆医学, 2017, 46(27): 3819-3821. doi: 10.3969/j.issn.1671-8348.2017.27.023
[14]	徐测梁, 王齐国. 老年心衰患者血清肌钙蛋白Ⅰ水平与心肌损伤的关系及ROC分析[J]. 中国老年学杂志, 2015, 35(11): 2979-2980. doi: 10.3969/j.issn.1005-9202.2015.11.044
[15]	顾遵才, 李勋, 王正忠, 等. 血清心脏肌球蛋白结合蛋白C检测在急性心肌梗死患者诊断中的作用[J]. 中国动脉硬化杂志, 2016, 24(9): 954-958. https://www.cnki.com.cn/Article/CJFDTOTAL-KDYZ201609017.htm
[16]	高华, 张振英, 张建秀, 等. 不同剂量培哚普利对高血压合并慢性心力衰竭患者运动心肺功能的研究[J]. 中国医刊, 2014, 49(2): 36-38. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYI201402016.htm
[17]	苏衡, 王广艳, 朱君, 等. 米力农注射液治疗高血压性心脏病伴心力衰竭的临床观察[J]. 中国药房, 2017, 28(5): 677-680. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYA201705028.htm
[18]	熊青, 聂荣杰, 陈绵雄, 等. 高血压性心脏病与糖尿病性心肌病左心功能差异研究[J]. 中国循证心血管医学杂志, 2016, 8(4): 411-414. doi: 10.3969/j.issn.1674-4055.2016.04.08
[19]	单海慧, 张丽红. 美托洛尔治疗老年高血压性心脏病室性心律失常的疗效[J]. 中国老年学杂志, 2018, 38(12): 2857-2858. doi: 10.3969/j.issn.1005-9202.2018.12.017
[20]	王椿野, 王嘉麟, 邢佳, 等. 从"损其心者, 调其营卫"思考高血压性心脏病[J]. 环球中医药, 2016, 9(3): 345-347. https://www.cnki.com.cn/Article/CJFDTOTAL-HQZY201603036.htm

Cited By

Get Citation

PDF

XML

Article views (310) PDF downloads (7)

Turn off MathJax

Article Contents

Abstract

References

Effect of milrinone injection for hypertensive heart disease patients with heart failure and its influence on exercise tolerance

Abstract

References

Catalog

Export File

Citation

Format

Content